SEALSQ Corp current report, Q1 FY2024

Full document

SEALSQ Corp. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K, dated March 4, 2024, reports financing activity completed by SEALSQ Corp. during March 2024. The company is a British Virgin Islands foreign private issuer listed on Nasdaq and files annual reports on Form 20-F.

Financing and Key Financial Metrics

  • On March 1, 2024, SEALSQ closed a third financing tranche with aggregate principal of $10.0 million.
  • The financing consists of 2.5% senior original issue discount convertible notes due 2026. The 2.5% discount results in approximately $9.75 million of proceeds before expenses.
  • The notes are convertible at the lesser of $5.50 per ordinary share or 93% of the lowest volume-weighted average price during the preceding 10 trading days, subject to a $0.55 floor that may be reduced by mutual consent.
  • Investors also received five-year warrants to purchase 1,537,358 ordinary shares at an exercise price of $5.50 per share. Cashless exercise is available after six months if the applicable resale registration statement is not effective.
  • The filing does not provide revenue, operating profit, net income, cash flow, margins, total liquidity, or a complete debt balance for the reporting period.
  • Including the previously disclosed first and second tranches, the transaction program has involved up to $30.0 million of note principal, before any conversions and excluding potential future tranches.

Material Changes Versus Prior Comparable Financing

  • The third tranche uses a 2.5% original issue discount, compared with 4% original issue discounts for the first and second tranches.
  • The fixed conversion and warrant exercise price for the third tranche was increased from $4.00 to $5.50, while the variable conversion price remains subject to a $0.55 floor.
  • Investors agreed to commercially reasonable efforts to limit weekly sales of third-tranche conversion shares and warrant shares to 10% of average weekly trading volume, subject to exceptions.
  • As of the filing, investors had converted all first-tranche notes into 9,717,438 ordinary shares and had converted $5.1 million of second-tranche notes into 3,069,970 ordinary shares.
  • The company reported 20,297,092 ordinary shares outstanding as of the filing date. Additional conversions and warrant exercises could materially increase the share count.

Outlook, Risks, Contingencies, and Unusual Items

  • Fourth and fifth tranches may be issued, subject to mutual consent and other closing conditions, with up to $10.0 million of additional principal in each tranche.
  • The company must file a registration statement covering third-tranche conversion shares and warrant shares within 30 trading days after the March 1 closing and intends to have it declared effective as soon as practicable.
  • Registration statements for any fourth or fifth tranche securities would be due within 20 trading days after the applicable closing.
  • The company agreed to maintain a reserve of 40 million ordinary shares for third-tranche obligations.
  • Investors waived, solely for the third tranche, certain restrictions on additional indebtedness. The waiver permits specified indebtedness, including up to $2.0 million payable to Cisco Systems and certain affiliate loans subject to stated limits.
  • The notes contain variable-price conversion and anti-dilution provisions, creating potential dilution and possible downward pressure on the ordinary share price.
  • The filing does not provide management guidance regarding revenue, earnings, cash flow, or operating performance.

Investor Verification Checklist

  • Verify the final terms, maturity, interest, default provisions, and conversion mechanics in the executed third-tranche note.
  • Monitor the effectiveness and timing of the third-tranche resale registration statement.
  • Reconcile subsequent conversions, warrant exercises, and the resulting fully diluted share count.
  • Assess whether fourth and fifth tranches are completed and their impact on debt, liquidity, and dilution.
  • Review the company’s next periodic filing for actual cash proceeds, financing costs, outstanding debt, liquidity, and any required derivative or conversion-accounting adjustments.